Other Species / Isoforms
  IRF2BP1 (human)      LTP 

LTP (Low Throughput Papers) : The number of records in which this modification site was determined using methods other than discovery mass spectrometry.

 HTP 

HTP (High Throughput Papers): The number of records in which this modification site was assigned using ONLY proteomic discovery mass spectrometry.

 
S58-p
AARQLKRsHVLPEGR
0 1
IRF2BP1 (human) AARQLKRsHVLPEGR S58-p
IRF2BP1 (mouse) AARQLKRSHVLPEGR S58
IRF2BP1 (rat) AARQLKRSHVLPEGR S58
S66-p
HVLPEGRsPGPPALK
Upstream
0 27
Treatment
  • LRRK2-IN-1
IRF2BP1 (human) HVLPEGRsPGPPALK S66-p
IRF2BP1 (mouse) HVLPEGRsPGPPALK S66-p
IRF2BP1 (rat) HVLPEGRsPGPPALK S66-p
R120-m1
DRATSSGrLPLPsPA
0 1
IRF2BP1 (human) DRATSSGrLPLPsPA R120-m1
IRF2BP1 (mouse) DRATSSSRLALPsPA R120
IRF2BP1 (rat) DRATSSSRLALPsPA R120
S125-p
SGrLPLPsPALEyTL
Upstream
0 18
Treatment
  • ischemia
IRF2BP1 (human) SGrLPLPsPALEyTL S125-p
IRF2BP1 (mouse) SSRLALPsPALEYTL S125-p
IRF2BP1 (rat) SSRLALPsPALEYTL S125-p
Y130-p
LPsPALEyTLGSRLA
0 1
IRF2BP1 (human) LPsPALEyTLGSRLA Y130-p
IRF2BP1 (mouse) LPsPALEYTLGSRLA Y130
IRF2BP1 (rat) LPsPALEYTLGSRLA Y130
R177-m1
AVSGLGSrGLTLAPG
0 3
IRF2BP1 (human) AVSGLGSrGLTLAPG R177-m1
IRF2BP1 (mouse) AVSGLGGRALTLAPG R177
IRF2BP1 (rat) AVSGLGGRALTLAPG R177
S186-p
LTLAPGLsPArPLFG
Upstream
0 15
Treatment
  • nocodazole
IRF2BP1 (human) LTLAPGLsPArPLFG S186-p
IRF2BP1 (mouse) LTLAPGLsPARPLFG S186-p
IRF2BP1 (rat) LTLAPGLSPARPLFG S186
R189-m1
APGLsPArPLFGsDF
0 1
IRF2BP1 (human) APGLsPArPLFGsDF R189-m1
IRF2BP1 (mouse) APGLsPARPLFGSDF R189
IRF2BP1 (rat) APGLSPARPLFGSDF R189
S194-p
PArPLFGsDFEKEKQ
0 1
IRF2BP1 (human) PArPLFGsDFEKEKQ S194-p
IRF2BP1 (mouse) PARPLFGSDFEKEKQ S194
IRF2BP1 (rat) PARPLFGSDFEKEKQ S194
K227-ub
EEWHGRPkAVREQLL
0 1
IRF2BP1 (human) EEWHGRPkAVREQLL K227-ub
IRF2BP1 (mouse) EEWHGRPKAVREQLL K227
IRF2BP1 (rat) EEWHGRPKAVREQLL K227
S237-p
REQLLALsACAPFNV
0 1
IRF2BP1 (human) REQLLALsACAPFNV S237-p
IRF2BP1 (mouse) REQLLALSACAPFNV S237
IRF2BP1 (rat) REQLLALSACAPFNV S237
R245-m1
ACAPFNVrFkKDHGL
0 1
IRF2BP1 (human) ACAPFNVrFkKDHGL R245-m1
IRF2BP1 (mouse) ACAPFNVRFKKDHGL R245
IRF2BP1 (rat) ACAPFNVRFKKDHGL R245
K247-ub
APFNVrFkKDHGLVG
0 1
IRF2BP1 (human) APFNVrFkKDHGLVG K247-ub
IRF2BP1 (mouse) APFNVRFKKDHGLVG K247
IRF2BP1 (rat) APFNVRFKKDHGLVG K247
Y268-p
ATARPPGyEFELKLF
0 5
IRF2BP1 (human) ATARPPGyEFELKLF Y268-p
IRF2BP1 (mouse) ATARPPGYEFELKLF Y268
IRF2BP1 (rat) ATARPPGYEFELKLF Y268
K306-ub
DALREPGkALASSGF
0 2
IRF2BP1 (human) DALREPGkALASSGF K306-ub
IRF2BP1 (mouse) DALREPGKALASSGF K306
IRF2BP1 (rat) DALREPGKALASSGF K306
K314-ub
ALASSGFkYLEYERR
0 4
IRF2BP1 (human) ALASSGFkYLEYERR K314-ub
IRF2BP1 (mouse) ALASSGFkYLEYERR K314-ub
IRF2BP1 (rat) ALASSGFKYLEYERR K314
K314-sm
ALASSGFkYLEYERR
0 1
IRF2BP1 (human) ALASSGFkYLEYERR K314-sm
IRF2BP1 (mouse) ALASSGFKYLEYERR K314
IRF2BP1 (rat) ALASSGFKYLEYERR K314
Y354-p
AEALPQQyPEPAPAA
0 1
IRF2BP1 (human) AEALPQQyPEPAPAA Y354-p
IRF2BP1 (mouse) AEALPQQYPEPAPAA Y354
IRF2BP1 (rat) AEALPQQYPEPAPAA Y354
S371-p
GPPPRAPsRNLAPtP
0 14
IRF2BP1 (human) GPPPRAPsRNLAPtP S371-p
IRF2BP1 (mouse) GPPPRAPsRNLAPtP S371-p
IRF2BP1 (rat) GPPPRAPSRNLAPTP S371
T377-p
PsRNLAPtPRRRkAs
0 16
IRF2BP1 (human) PsRNLAPtPRRRkAs T377-p
IRF2BP1 (mouse) PsRNLAPtPRRRKAs T377-p
IRF2BP1 (rat) PSRNLAPTPRRRKAs T377
K382-sm
APtPRRRkAsPEPEG
0 1
IRF2BP1 (human) APtPRRRkAsPEPEG K382-sm
IRF2BP1 (mouse) APtPRRRKAsPEPEG K382
IRF2BP1 (rat) APTPRRRKAsPEPEG K382
S384-p
tPRRRkAsPEPEGEA
0 44
IRF2BP1 (human) tPRRRkAsPEPEGEA S384-p
IRF2BP1 (mouse) tPRRRKAsPEPEGET S384-p
IRF2BP1 (rat) TPRRRKAsPEPEGET S384-p
S413-p
VAPGGPYsAEtPGVP
0 2
IRF2BP1 (human) VAPGGPYsAEtPGVP S413-p
IRF2BP1 (mouse) VAPGGPYSSETPGVP S413
IRF2BP1 (rat) VAPGGPYSTETPGVP S413
T416-p
GGPYsAEtPGVPsPI
0 3
IRF2BP1 (human) GGPYsAEtPGVPsPI T416-p
IRF2BP1 (mouse) GGPYSSETPGVPsPI T416
IRF2BP1 (rat) GGPYSTETPGVPsPI T416
S421-p
AEtPGVPsPIAALKN
Upstream
0 34
Treatment
  • BI_4834
  • ischemia
  • LRRK2-IN-1
  • nocodazole
IRF2BP1 (human) AEtPGVPsPIAALKN S421-p
IRF2BP1 (mouse) SETPGVPsPIAALKN S421-p
IRF2BP1 (rat) TETPGVPsPIAALKN S421-p
S436-p
VAEALGHsPkDPGGG
Upstream
0 70
Treatment
  • nocodazole
IRF2BP1 (human) VAEALGHsPkDPGGG S436-p
IRF2BP1 (mouse) VAEALGHsPKDPGGG S436-p
IRF2BP1 (rat) VAEALGHsPKDPGGG S436-p
K438-ub
EALGHsPkDPGGGGG
0 1
IRF2BP1 (human) EALGHsPkDPGGGGG K438-ub
IRF2BP1 (mouse) EALGHsPKDPGGGGG K438
IRF2BP1 (rat) EALGHsPKDPGGGGG K438
P446
DPGGGGGPVRAGGAs
0 1
IRF2BP1 (human) DPGGGGGPVRAGGAs P446
IRF2BP1 (mouse) DPGGGGGsVRAGGAs S446-p
IRF2BP1 (rat) DPGGGGGSVRAGGAs S446
S453-p
PVRAGGAsPAAsSTA
Upstream
0 64
Treatment
  • LRRK2-IN-1
IRF2BP1 (human) PVRAGGAsPAAsSTA S453-p
IRF2BP1 (mouse) sVRAGGAsPAAsSTT S453-p
IRF2BP1 (rat) SVRAGGAsPAASSTT S453-p
S457-p
GGAsPAAsSTAQPPT
0 2
IRF2BP1 (human) GGAsPAAsSTAQPPT S457-p
IRF2BP1 (mouse) GGAsPAAsSTTQPPA S457-p
IRF2BP1 (rat) GGAsPAASSTTQPPT S457
S478-p
RNGEAEVsPTAGAEA
0 3
IRF2BP1 (human) RNGEAEVsPTAGAEA S478-p
IRF2BP1 (mouse) RNGEAEVsPTAGAEA S478-p
IRF2BP1 (rat) RNGEAEVSPTAGAEA S478